For US Healthcare Professionals only.
For US Healthcare Professionals only. Not a HCP, visit rayner.com
Get in touch with us:
Request a Sales Representative
To be contacted by a Sales Representative from Rayner, call 1-844-RAYNER1, email omidriahcp@rayner.com, or submit your request below
Request a Field Reimbursement Manager
To speak with a Field Reimbursement Manager about access and reimbursement, call 1-844-RAYNER1, email omidriafrms@rayner.com, or submit your request below
OMIDRIAssure®
For general information about OMIDRIAssure, please contact your Field Reimbursement Manager at omidriafrms@rayner.com or call
1-877-OMIDRIA
Request Medical Information
To contact our medical information services, call 1-877-OMIDRIA or submit your request below
Product Concerns and Adverse Reactions
For any product concerns, please call
1-877-OMIDRIA. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or visit the site below
For general inquiries about OMIDRIA or Rayner, please call 1-844-RAYNER1.
Indications and Usage
OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
Important Safety Information
OMIDRIA must be added to irrigating solution prior to intraocular use.
OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure to phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.
You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Indications and Usage
OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
Important Safety Information
OMIDRIA must be added to irrigating solution prior to intraocular use.
OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure to phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.
You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.